Van ECK Associates Corp Trims Position in Haleon plc (NYSE:HLN)

Van ECK Associates Corp trimmed its holdings in shares of Haleon plc (NYSE:HLNFree Report) by 8.0% in the 4th quarter, HoldingsChannel.com reports. The fund owned 2,272,830 shares of the company’s stock after selling 197,465 shares during the quarter. Van ECK Associates Corp’s holdings in Haleon were worth $18,705,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors have also made changes to their positions in HLN. Pinnacle Bancorp Inc. lifted its position in Haleon by 853.4% during the fourth quarter. Pinnacle Bancorp Inc. now owns 4,767 shares of the company’s stock valued at $39,000 after purchasing an additional 4,267 shares during the period. FinTrust Capital Advisors LLC raised its stake in shares of Haleon by 93.7% during the 3rd quarter. FinTrust Capital Advisors LLC now owns 5,557 shares of the company’s stock valued at $46,000 after buying an additional 2,688 shares during the last quarter. NBC Securities Inc. acquired a new position in shares of Haleon in the 3rd quarter valued at about $82,000. Hoxton Planning & Management LLC purchased a new stake in shares of Haleon in the fourth quarter worth about $85,000. Finally, Rehmann Capital Advisory Group purchased a new stake in shares of Haleon in the third quarter worth about $91,000. 6.67% of the stock is owned by hedge funds and other institutional investors.

Haleon Trading Down 2.2 %

HLN stock opened at $8.34 on Thursday. Haleon plc has a 52-week low of $7.70 and a 52-week high of $8.98. The company has a quick ratio of 0.73, a current ratio of 1.04 and a debt-to-equity ratio of 0.53. The firm has a market cap of $38.08 billion, a P/E ratio of 29.79, a PEG ratio of 2.23 and a beta of 0.28. The company’s 50-day simple moving average is $8.34 and its 200-day simple moving average is $8.29.

Haleon Announces Dividend

The firm also recently declared a semi-annual dividend, which will be paid on Thursday, May 16th. Shareholders of record on Friday, March 15th will be given a dividend of $0.1064 per share. The ex-dividend date is Thursday, March 14th. This represents a yield of 1.8%. Haleon’s dividend payout ratio is currently 75.00%.

Wall Street Analyst Weigh In

HLN has been the subject of several recent research reports. Argus reiterated a “buy” rating on shares of Haleon in a research report on Tuesday, March 26th. HSBC initiated coverage on shares of Haleon in a report on Wednesday, April 17th. They set a “buy” rating for the company. Two analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy”.

View Our Latest Stock Analysis on HLN

Haleon Company Profile

(Free Report)

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.

See Also

Want to see what other hedge funds are holding HLN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Haleon plc (NYSE:HLNFree Report).

Institutional Ownership by Quarter for Haleon (NYSE:HLN)

Receive News & Ratings for Haleon Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Haleon and related companies with MarketBeat.com's FREE daily email newsletter.